December 2004: Pharmaceutical Industry on the Radar

Drug costs are the fastest growing part of Health Care spending in the US. This fact made drug prices one of the hot buttons in the 2004 election. Public opinion is charged against the pharmaceutical companies and voters are expecting changes over the next four years. The consensus? Patients, and particularly seniors, are paying too much for drugs, and prices need to go down. Reforms proposed? Some of these include re-importation from Canada, Medicare, and more flexibility for generic drugs. Find out about the issues discussed in the election debate, the proposed reforms, and what the PR pharmaceutical industry should expect in the near future.